First American Trust, Fsb Gilead Sciences, Inc. Transaction History

First American Trust, Fsb

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Jan 28, 2021	SELL	$56.65 - $64.55 $205,469 - $234,122	-3,627 Closed	0 $0
Q3 2020 Oct 14, 2020	SELL	$62.1 - $78.08 $2.29 Million - $2.88 Million	-36,870 Reduced 91.04%	3,627 $229,000
Q2 2020 Jul 08, 2020	BUY	$72.34 - $84.0 $229,968 - $267,036	3,179 Added 8.52%	40,497 $3.12 Million
Q1 2020 Apr 28, 2020	BUY	$62.63 - $80.22 $2.34 Million - $2.99 Million	37,318 New	37,318 $2.79 Million

1,923

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of First American Trust, Fsb, based on Form 13F filings with the SEC.

Stay updated on First American Trust, Fsb with notifications on news.